The Cancer & Hematology Centers recognizes Dr. Yuanbin Chen for his work on the following trial: Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden: Read Full Article here.
Here, we report the results of exploratory analyses of PD-L1 expression and tissue TMB (tTMB), and the relationship of these biomarkers with outcomes, in patients with treatment-naïve ES-SCLC in the CASPIAN study.
Founded in 1979, CHC has grown to become the largest physician-owned oncology and hematology practice in Michigan. We deliver advanced care in a personal way, and our expertise and caring approach make us dedicated to the help, healing and hope for cancer patients and their families.
Contact Information